Bacterial external ventricular catheter-associated infection

Expert Rev Anti Infect Ther. 2020 Mar;18(3):219-229. doi: 10.1080/14787210.2020.1717949. Epub 2020 Jan 29.

Abstract

Introduction: 9-20% of the patients with an external ventricular drain develop a catheter-associated infection.Areas covered: This review summarizes the diagnostic process and management of bacterial external ventricular catheter-associated infection.Expert commentary: Current literature shows that no single CSF-, blood- or microbiological measure can be used to differentiate between an infection and sterile inflammation. The gold standard of diagnosis remains CSF culture. Empiric antimicrobial treatment consists of vancomycin combined with an anti-pseudomonal β-lactam. The increase in multi-drug resistant Gram-negative bacteria is an emerging problem in the treatment. Preventive measures and antibiotic-impregnated drains have shown to contribute to reducing incidence of external ventricular drain-associated infections.

Keywords: External ventricular catheter-associated infection; cerebrospinal fluid; diagnosis; therapy; ventriculitis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology
  • Catheter-Related Infections / diagnosis*
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / microbiology
  • Drainage / instrumentation
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Humans
  • Inflammation / diagnosis

Substances

  • Anti-Bacterial Agents